|
CALCOCO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.181510E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.818400E-04 |
| Normal-vs-Stage2 |
2.917800E-01 |
| Normal-vs-Stage3 |
2.430600E-01 |
| Normal-vs-Stage4 |
3.202200E-01 |
| Stage1-vs-Stage2 |
4.246400E-01 |
| Stage1-vs-Stage3 |
3.234200E-01 |
| Stage1-vs-Stage4 |
8.228600E-01 |
| Stage2-vs-Stage3 |
9.594400E-01 |
| Stage2-vs-Stage4 |
7.545000E-01 |
| Stage3-vs-Stage4 |
7.062000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.222760E-03 |
| Normal-vs-AfricanAmerican |
2.062000E-02 |
| Normal-vs-Asian |
7.755400E-01 |
| Caucasian-vs-AfricanAmerican |
8.935200E-01 |
| Caucasian-vs-Asian |
6.170600E-01 |
| AfricanAmerican-vs-Asian |
6.216200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.392820E-04 |
| Normal-vs-Female |
4.332400E-01 |
| Male-vs-Female |
5.151900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.604600E-03 |
| Normal-vs-Extreme_Weight |
1.785520E-04 |
| Normal-vs-Obese |
6.222000E-02 |
| Normal-vs-Extreme_Obese |
1.050630E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.489400E-01 |
| Normal_Weight-vs-Obese |
2.245600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.251200E-01 |
| Extreme_Weight-vs-Obese |
1.433190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.788400E-01 |
| Obese-vs-Extreme_Obese |
3.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.596390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.167000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.53680000003487E-06 |
| Normal-vs-Age(81-100Yrs) |
5.823900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.924400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.357600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.138300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.435790E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.735900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.641400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.224450E-03 |
| Normal-VS-Type2 PRCC |
1.638090E-02 |
| Normal-VS-KIRP CIMP |
2.085800E-01 |
| Normal-VS-Unclassified PRCC |
5.439400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.134400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.583100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.129400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.771900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.975400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.608400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.723300E-03 |
| Normal-vs-N1 |
8.985200E-01 |
| Normal-vs-N2 |
9.262400E-01 |
| N0-vs-N1 |
8.342300E-02 |
| N0-vs-N2 |
4.535800E-01 |
| N1-vs-N2 |
9.431600E-01 |
|
|
